telmisartan has been researched along with Anoxemia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Lin, Y; Luo, W; Shi, Y; Song, A; Wang, W; Zeng, Y; Zhang, Y | 1 |
| Cai, JH; Cheng, X; Ewurum, HC; Luo, X; Wang, M; Yang, YY; Zeng, HQ; Zeng, YM; Zhang, XB | 1 |
| Deng, Y; Guo, XL; Liu, HG; Liu, K; Shang, J; Yuan, X; Zhu, D | 1 |
| Deng, Y; Guo, X; Liu, H; Shang, J; Yuan, X; Zhu, D | 1 |
| Agostoni, P; Bilo, G; Branzi, G; Ciambellotti, F; Faini, A; Giuliano, A; Gregorini, F; Lombardi, C; Malfatto, G; Mancia, G; Osculati, G; Parati, G; Revera, M | 1 |
| Agostoni, P; Bilo, G; Bonacina, D; Bussotti, M; Faini, A; Giuliano, A; Lombardi, C; Mancia, G; Meriggi, P; Modesti, PA; Parati, G; Revera, M; Swenson, ER | 1 |
| Bilo, G; Caldara, G; Chinello, C; Gianazza, E; Giuliano, A; Lombardi, C; Magni, F; Mainini, V; Parati, G; Piperno, A; Revera, M | 1 |
| Chen, XY; Wan, WY; Wang, WY; Zeng, YM; Zhang, YX | 1 |
| Agostoni, P; Bilo, G; Caldara, G; Castiglioni, P; Di Rienzo, M; Faini, A; Gregorini, F; Lombardi, C; Mancia, G; Maurizio, B; Meriggi, P; Parati, G; Revera, M | 1 |
4 trial(s) available for telmisartan and Anoxemia
| Article | Year |
|---|---|
Effects of hypobaric hypoxia exposure at high altitude on left ventricular twist in healthy subjects: data from HIGHCARE study on Mount Everest.
Topics: Adult; Aged; Altitude; Altitude Sickness; Analysis of Variance; Benzimidazoles; Benzoates; Double-Blind Method; Drug Administration Schedule; Echocardiography, Doppler; Female; Follow-Up Studies; Healthy Volunteers; Humans; Hypoxia; Image Interpretation, Computer-Assisted; Male; Middle Aged; Oxygen Consumption; Reference Values; Telmisartan; Ventricular Dysfunction, Left | 2016 |
High-altitude exposure of three weeks duration increases lung diffusing capacity in humans.
Topics: Acclimatization; Adult; Altitude; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Biomarkers; Blood-Air Barrier; Capillary Permeability; Female; Hemoglobins; Humans; Hypoxia; Italy; Lung; Male; Middle Aged; Mountaineering; Nepal; Norepinephrine; Oxygen; Pulmonary Diffusing Capacity; Telmisartan; Time Factors | 2011 |
Modulation of urinary peptidome in humans exposed to high altitude hypoxia.
Topics: Adult; Altitude; Benzimidazoles; Benzoates; Chronic Disease; Double-Blind Method; Female; Humans; Hypoxia; Male; Middle Aged; Peptides; Proteome; Proteomics; Telmisartan; White People | 2012 |
High-altitude hypoxia and periodic breathing during sleep: gender-related differences.
Topics: Actigraphy; Adult; Altitude; Altitude Sickness; Angiotensin II Type 1 Receptor Blockers; Atmospheric Pressure; Benzimidazoles; Benzoates; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Female; Heart Rate; Humans; Hypoxia; Male; Middle Aged; Monitoring, Ambulatory; Oxygen; Placebos; Respiratory Rate; Severity of Illness Index; Sex Factors; Sleep; Sleep Apnea, Central; Telmisartan; Time Factors | 2013 |
5 other study(ies) available for telmisartan and Anoxemia
| Article | Year |
|---|---|
Telmisartan protects chronic intermittent hypoxic mice via modulating cardiac renin-angiotensin system activity.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Chronic Disease; Disease Models, Animal; Endothelial Cells; Heart Diseases; Hypoxia; Male; Mice, Inbred C57BL; Mitochondria, Heart; Myocardium; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Telmisartan | 2018 |
Telmisartan attenuates kidney apoptosis and autophagy-related protein expression levels in an intermittent hypoxia mouse model.
Topics: Angiotensin II; Animals; Apoptosis; Autophagy-Related Proteins; Blood Urea Nitrogen; Body Weight; Creatinine; Disease Models, Animal; Hypoxia; In Situ Nick-End Labeling; Kidney; Male; Mice; Mice, Inbred C57BL; Telmisartan | 2019 |
Telmisartan attenuates myocardial apoptosis induced by chronic intermittent hypoxia in rats: modulation of nitric oxide metabolism and inflammatory mediators.
Topics: Animals; Apoptosis; Benzimidazoles; Benzoates; C-Reactive Protein; Disease Models, Animal; Hypoxia; Inflammation Mediators; Interleukin-6; Lipid Peroxidation; Male; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Sleep Apnea, Obstructive; Telmisartan | 2015 |
Chronic intermittent hypoxia-induced neuronal apoptosis in the hippocampus is attenuated by telmisartan through suppression of iNOS/NO and inhibition of lipid peroxidation and inflammatory responses.
Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Benzimidazoles; Benzoates; C-Reactive Protein; Disease Models, Animal; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Hippocampus; Hypoxia; In Situ Nick-End Labeling; Inflammation; Interleukin-6; Leukocyte Common Antigens; Lipid Peroxidation; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Telmisartan | 2015 |
Effect of Telmisartan on local cardiovascular oxidative stress in mouse under chronic intermittent hypoxia condition.
Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biomarkers; Chronic Disease; Disease Models, Animal; Hypoxia; Male; Mice; Mice, Inbred Strains; Myocardium; NADPH Oxidases; Oxidative Stress; Reference Values; Sleep Apnea, Obstructive; Telmisartan | 2013 |